Latest Insider Transactions at Surmodics Inc (SRDX)
This section provides a real-time view of insider transactions for Surmodics Inc (SRDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SURMODICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SURMODICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2024
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,569
-19.98%
|
$2,022,760
$40.06 P/Share
|
|
Aug 21
2024
|
Gary R Maharaj President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
61,017
+19.42%
|
$2,013,561
$33.2 P/Share
|
|
Aug 21
2024
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
19,434
-23.3%
|
$777,360
$40.06 P/Share
|
|
Aug 21
2024
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Exercise of conversion of derivative security
|
Direct |
21,285
+20.33%
|
$702,405
$33.2 P/Share
|
|
Aug 16
2024
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,729
-17.78%
|
$669,160
$40.06 P/Share
|
|
Aug 16
2024
|
Timothy J. Arens Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,447
+16.39%
|
$608,751
$33.2 P/Share
|
|
Aug 16
2024
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
16,727
-23.66%
|
$669,080
$40.06 P/Share
|
|
Aug 16
2024
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Exercise of conversion of derivative security
|
Direct |
18,447
+20.69%
|
$608,751
$33.2 P/Share
|
|
Feb 08
2024
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
1,803
+4.41%
|
-
|
|
Feb 08
2024
|
Jose H Bedoya |
BUY
Grant, award, or other acquisition
|
Direct |
1,803
+5.86%
|
-
|
|
Feb 08
2024
|
Jose H Bedoya |
SELL
Payment of exercise price or tax liability
|
Direct |
2,954
-9.81%
|
$91,574
$31.89 P/Share
|
|
Feb 08
2024
|
Jose H Bedoya |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+11.55%
|
$90,436
$23.95 P/Share
|
|
Feb 08
2024
|
Susan E Knight |
BUY
Grant, award, or other acquisition
|
Direct |
1,944
+5.24%
|
-
|
|
Feb 08
2024
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
1,803
+4.5%
|
-
|
|
Feb 08
2024
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
1,803
+11.82%
|
-
|
|
Feb 05
2024
|
Susan E Knight |
SELL
Payment of exercise price or tax liability
|
Direct |
3,063
-8.45%
|
$91,890
$30.75 P/Share
|
|
Feb 05
2024
|
Susan E Knight |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+9.78%
|
$90,436
$23.95 P/Share
|
|
Jan 19
2024
|
David Dantzker |
SELL
Payment of exercise price or tax liability
|
Direct |
2,773
-6.92%
|
$91,509
$33.97 P/Share
|
|
Jan 19
2024
|
David Dantzker |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+8.93%
|
$90,436
$23.95 P/Share
|
|
Dec 29
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
491
+1.33%
|
$17,676
$36.35 P/Share
|
|
Dec 27
2023
|
Ronald B Sr Kalich |
SELL
Payment of exercise price or tax liability
|
Direct |
2,545
-6.61%
|
$94,165
$37.01 P/Share
|
|
Dec 27
2023
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
3,932
+9.26%
|
$90,436
$23.95 P/Share
|
|
Dec 04
2023
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,323
+9.91%
|
-
|
|
Dec 04
2023
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,942
+12.72%
|
-
|
|
Dec 04
2023
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,486
+15.16%
|
-
|
|
Dec 04
2023
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
6,302
+10.76%
|
-
|
|
Dec 04
2023
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
9,274
+20.35%
|
-
|
|
Dec 04
2023
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
6,302
+9.25%
|
-
|
|
Dec 04
2023
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
6,539
+22.86%
|
-
|
|
Nov 30
2023
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
455
-2.12%
|
$14,560
$32.82 P/Share
|
|
Nov 30
2023
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
2,185
-1.54%
|
$69,920
$32.82 P/Share
|
|
Nov 30
2023
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,749
-2.07%
|
$55,968
$32.82 P/Share
|
|
Nov 30
2023
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,356
-1.38%
|
$75,392
$32.82 P/Share
|
|
Nov 30
2023
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-2.96%
|
$46,912
$32.82 P/Share
|
|
Nov 30
2023
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,437
-1.18%
|
$77,984
$32.82 P/Share
|
|
Nov 30
2023
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,110
-1.79%
|
$291,520
$32.82 P/Share
|
|
Nov 15
2023
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
10,803
-18.33%
|
$356,499
$33.82 P/Share
|
|
Nov 15
2023
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Exercise of conversion of derivative security
|
Direct |
12,841
+17.89%
|
$295,343
$23.95 P/Share
|
|
Nov 15
2023
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
14,583
-20.13%
|
$481,239
$33.82 P/Share
|
|
Nov 15
2023
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Exercise of conversion of derivative security
|
Direct |
17,121
+19.12%
|
$393,783
$23.95 P/Share
|
|
Sep 29
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
557
+1.58%
|
$17,824
$32.09 P/Share
|
|
Jun 30
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
570
+1.65%
|
$17,670
$31.31 P/Share
|
|
Mar 31
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
784
+2.29%
|
$17,248
$22.78 P/Share
|
|
Feb 09
2023
|
Susan E Knight |
BUY
Grant, award, or other acquisition
|
Direct |
2,139
+6.2%
|
-
|
|
Feb 09
2023
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
1,984
+5.2%
|
-
|
|
Feb 09
2023
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
1,984
+14.55%
|
-
|
|
Feb 09
2023
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
1,984
+5.72%
|
-
|
|
Feb 09
2023
|
Jose H Bedoya |
BUY
Grant, award, or other acquisition
|
Direct |
1,984
+7.05%
|
-
|
|
Dec 31
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
523
+1.67%
|
$17,782
$34.12 P/Share
|
|
Nov 30
2022
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+9.35%
|
-
|